Boston Sci introduces smallest, thinnest high-energy CRT-Ds and ICDs

Boston Scientific announced Friday the launch and first implants of its Energen and Punctua cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators in Europe and other markets. They are the world's smallest and thinnest high-energy devices to treat heart failure and sudden cardiac death, according to a company statement. Boston Scientific received CE Mark approval for the devices last October and is hoping for FDA's OK for the devices later this year or early next. Boston Scientific statement

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.